Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Neurology(R) Neuroimmunology & Neuroinflammation|August 25, 2021
COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America: From the COViMS RegistryScott D Newsome, Anne H Cross, Robert J Fox, et al.
Multiple Sclerosis and Related Disorders|July 15, 2022
COVID-19 in the pregnant or postpartum MS patient: Symptoms and outcomesAmber Salter, Anne H Cross, Gary R Cutter, et al.
Neurology|April 21, 2025
Composite Confirmed Disability Worsening/Progression Is a Useful Clinical Endpoint for Multiple Sclerosis Clinical TrialsLudwig Kappos, Sean Yiu, Frank Dahlke, et al.
JAMA Neurology|March 19, 2021
Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple SclerosisAmber Salter, Robert J Fox, Scott D Newsome, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 26, 2025
The path to prevention of multiple sclerosis: Considerations for Epstein-Barr virus vaccine-based prevention studiesGregory K Zane, Anna Sutton, Amanda Brumwell, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 22, 2022
Improvement in time to multiple sclerosis diagnosis: 25-year retrospective analysis from New York State MS Consortium (NYSMSC)Dejan Jakimovski, Katelyn S Kavak, Karen Zakalik, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2004
Proteomic mapping provides powerful insights into functional myelin biologyChristopher M Taylor, Cecilia B Marta, Robert J Claycomb, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 27, 2025
Toward a global research agenda for preventing multiple sclerosisRuth Ann Marrie, Ruth Dobson, Sergio E Baranzini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 31, 2024
The first global landscape analysis of multiple sclerosis research fundingBruce Bebo, Tim Coetzee, Emma Gray, et al.
Neuron|December 3, 2014
Medicines for the mind: policy-based "pull" incentives for creating breakthrough CNS drugsDennis W Choi, Robert Armitage, Linda S Brady, et al.
Pageof 5